BioVaxys Technology Corp. (BVAXF)
USD 0.02
(-5.22%)
USD 0.02
(-5.22%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -7.68 Million CAD | 34.45% |
| 2022 | -11.72 Million CAD | -81.6% |
| 2021 | -6.45 Million CAD | -449.93% |
| 2020 | -1.17 Million CAD | -410.3% |
| 2019 | -230.12 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 518.04 Thousand CAD | 114.13% |
| 2024 Q2 | -542.38 Thousand CAD | -204.7% |
| 2024 Q3 | -1.18 Million CAD | -118.75% |
| 2023 Q2 | -1.48 Million CAD | -55.76% |
| 2023 Q1 | -956.04 Thousand CAD | 88.81% |
| 2023 FY | -7.68 Million CAD | 34.45% |
| 2023 Q4 | -3.66 Million CAD | -132.74% |
| 2023 Q3 | -1.57 Million CAD | -5.79% |
| 2022 Q4 | -8.54 Million CAD | -836.96% |
| 2022 Q3 | -912.16 Thousand CAD | 13.73% |
| 2022 FY | -11.72 Million CAD | -81.6% |
| 2022 Q2 | -1.05 Million CAD | 12.71% |
| 2022 Q1 | -1.21 Million CAD | 51.93% |
| 2021 Q4 | -2.51 Million CAD | -178.4% |
| 2021 FY | -6.45 Million CAD | -449.93% |
| 2021 Q3 | -905.08 Thousand CAD | 39.49% |
| 2021 Q2 | -1.49 Million CAD | 2.71% |
| 2021 Q1 | -1.53 Million CAD | -87.39% |
| 2020 Q3 | -254.85 Thousand CAD | -289.54% |
| 2020 Q1 | -33.61 Thousand CAD | 50.5% |
| 2020 FY | -1.17 Million CAD | -410.3% |
| 2020 Q4 | -820.42 Thousand CAD | -221.92% |
| 2020 Q2 | -65.42 Thousand CAD | -94.65% |
| 2019 Q3 | -37.82 Thousand CAD | 35.84% |
| 2019 Q1 | -65.44 Thousand CAD | 49.76% |
| 2019 FY | -230.12 Thousand CAD | 0.0% |
| 2019 Q4 | -67.9 Thousand CAD | -79.53% |
| 2019 Q2 | -58.95 Thousand CAD | 9.92% |
| 2018 Q4 | -130.25 Thousand CAD | -320.64% |
| 2018 Q3 | -30.96 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | -3.17 Million USD | -142.392% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -107.192% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -222.878% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 114.51% |
| GB Sciences, Inc. | -1.36 Million USD | -464.548% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -154.031% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -3269.753% |
| Skye Bioscience, Inc. | -37.64 Million USD | 79.579% |
| Zenith Capital Corp. | -10.59 Million USD | 27.451% |
| Agentix Corp. | -1.37 Million USD | -459.399% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -10.089% |
| Biomind Labs Inc. | -1.21 Million USD | -533.056% |
| ContraFect Corporation | -65.15 Million USD | 88.201% |
| CSL Limited | 2.64 Billion USD | 100.291% |
| CytoDyn Inc. | -49.84 Million USD | 84.576% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -294.373% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -1115.565% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 87.72% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -1750.23% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -322.258% |
| Regen BioPharma, Inc. | 1.02 Million USD | 851.075% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 111.803% |
| SQZ Biotechnologies Company | -79.46 Million USD | 90.326% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -254.285% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 89.745% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -165.777% |
| Mesoblast Limited | -87.95 Million USD | 91.26% |
| Marizyme, Inc. | -65.34 Million USD | 88.236% |
| Genus plc | 7.9 Million USD | 197.308% |
| Pharming Group N.V. | -10.54 Million USD | 27.121% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 13.079% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -345.008% |
| IMV Inc. | -36.48 Million USD | 78.931% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 4.62% |
| MultiCell Technologies, Inc. | -380.07 USD | -2022505.573% |
| ONE Bio Corp. | 8.67 Million USD | 188.598% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 85.129% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -105.929% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -147.837% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 2.73% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -51230.909% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 51.565% |
| Alpha Cognition Inc. | -13.77 Million USD | 44.184% |
| Enzolytics Inc. | -2.17 Million USD | -253.142% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 97.395% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 7944.201% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 211.015% |
| Genscript Biotech Corporation | -95.47 Million USD | 91.949% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -16.898% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -2711.727% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -85.418% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -12618.795% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -283.385% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 29.421% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -57.332% |
| Adynxx, Inc. | - USD | Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Accustem Sciences Inc. | -3.74 Million USD | -105.191% |
| Helix BioMedix, Inc. | -1.05 Million USD | -627.926% |
| EV Biologics, Inc. | -1.26 Million USD | -506.67% |
| Q BioMed Inc. | -2.05 Million USD | -274.609% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -101.291% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 87.129% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| BioStem Technologies, Inc. | -8.48 Million USD | 9.38% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -32.147% |
| HST Global, Inc. | -146.21 Thousand USD | -5157.723% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -475.643% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -338.081% |
| Halberd Corporation | -79.67 Thousand USD | -9548.222% |
| Resverlogix Corp. | -3.61 Million USD | -112.945% |
| Cell Source, Inc. | -5.32 Million USD | -44.466% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -93.489% |
| GeneThera, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | -6.41 Million USD | -19.859% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -32975.11% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | -4.76 Million USD | -61.187% |
| Kadimastem Ltd | -3.3 Million USD | -132.428% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -73.039% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -1641.698% |
| LadRx Corporation | 400.44 Thousand USD | 2019.703% |
| Regen BioPharma, Inc. | 1.02 Million USD | 851.075% |
| Affymax, Inc. | -14.42 Million USD | 46.705% |
| Itoco Inc. | -1.86 Million USD | -311.308% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -360.594% |
| Mobile Lads Corp. | -2.26 Million USD | -239.652% |
| International Stem Cell Corporation | -131 Thousand USD | -5768.181% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| Bioxytran, Inc. | -4.28 Million USD | -79.61% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -9626.718% |
| Qrons Inc. | -789.34 Thousand USD | -873.883% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -716.472% |
| SYBLEU INC | -180.3 Thousand USD | -4163.531% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -268.223% |
| Rebus Holdings, Inc. | -1.02 Million USD | -653.659% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -376.663% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -14064.425% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -203.817% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 84.009% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -263.638% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -884.434% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -142.655% |
| Neutra Corp. | -233.46 Thousand USD | -3192.706% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 62.115% |
| PureTech Health plc | -65.69 Million USD | 88.299% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 63.853% |
| IXICO plc | -1.17 Million USD | -552.574% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 22.562% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 86.544% |
| CSL Limited | 2.64 Billion USD | 100.291% |
| Cellectis S.A. | -103.17 Million USD | 92.549% |